Epilepsy and pregnancy; A delicate balance between risks to fetus and gravida;Epilepsi och graviditet: En balansgång mellan risker för mor och barn

Lakartidningen

Volumn , Issue 34, 1997, Pages 2827-2835

  Tomson, Torbjörn ^a   Danielsson, Bengt R ^b   Winbladh, Birger ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c SACHS CHILDREN S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

CONGENITAL MALFORMATION; EPILEPSY; FEMALE; HUMAN; MATERNAL WELFARE; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK FACTOR;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; MATERNAL WELFARE; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 9944256630     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Teramo K, Hiilesman VK. Pregnancy and fetal complications in epileptic pregnancies. In: Janz D, Dam M, Richens A, Bossi L, Helge H, Schmidt D, eds. Epilepsy, pregnancy and the child. New York: Raven Press, 1982:53-9.
2. Bardy AH. Incidence of seizures during pregnancy, labour and puerperium in epileptic women: a prospective study. Acta Neurol Scand 1987; 75: 356-60.
3. Gjerde IO, Strandjord RE, Ulstein M. The course of epilepsy during pregnancy: a study of 78 cases. Acta Neurol Scand 1988; 78: 198-205.
4. Tomson T, Lindblom U, Ekqvist B, Sundqvist A. Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin. Epilepsia 1994; 35: 122-30.
5. Vinge E. Breast-feeding and antiepileptic drugs. In: Tomson T, Gram L, Sillanpää M, Johannessen SI, eds. Epilepsy and pregnancy. Petersfield: Wrightson Biomedical Publishing Ltd, 1997: 93-103.
6. Bertollini R, Källén B, Mastroiacovo P, Robert E. Anticonvulsant drugs in monotherapy. Effects on the fetus. Eur J Epidemiol 1987; 3: 164-71.
7. Dansky LV, Finnell LV. Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiological and experimental findings spanning three decades; 2: human studies. Reprod Toxicol 1991; 5: 301-35.
8. Samrén EB, Lindhout D. Major malformations associated with maternal use of antiepileptic drugs. In: Tomson T, Gram L, Sillanpää M, Johannessen SI, eds. Epilepsy and pregnancy. Petersfield: Wrightson Biomedical Publishing Ltd 1997: 43-62.
9. Lindhout D, Meinardi H, Earth PG. Hazards of fetal exposure to drug combinations. In: Janz D, Dam M, Richens A, Bossi L, Helge H, Schmidt D, eds. Epilepsy, pregnancy, and the child. New York: Raven Press, 1982: 275-81.
10. Lindhout D, Meinardi H, Meijer JWA, Nau J. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by change in pattern of malformations. Neurology 1992; 42(5 suppl): 94-110.
11. Källén B, Robert E, Mastroiacovo P, Martinez-Frias ML, Castilla EE, Cocchi G. Anticonvulsant drugs and malformations: is there a drug specificity ? Eur J Epidemiol 1989; 5:31-6.
12. Robert E, Löfkvist E, Maugière F, Robert JM. Evaluation of drug therapy and teratogenic risk in a Rhône-Alpes district population of pregnant epileptic women. Eur Neurol 1986; 25: 436-43.
13. Gaily E, Granström ML, Hillesmaa V, Bardy A. Minor anomalies in offspring of epileptic mothers. J Pediatr 1988; 112: 520-9.
14. Danielsson BR, Webster WS. Cardiovascular active drugs. In: Kavlock RJ, Dastomn G, eds. Development drug toxicity in embryonic development. Handbook of experimental pharmacology. New York: SpringerVerlag, 1997: 161-90.
15. Danielsson BR, Azarbayani F, Wisén AC, Webster WS. Initiation of phenytoin teratogenesis: Pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation. Teratology 1997 (under publ).
16. Fantel AG, Person RE, Tumbic RW, Nguyen TD, MacKler B. Studies of mitochondria in oxidative embryoloxicity. Teratology 1995; 52: 190-5.
17. Czeizel AE, Dudás I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-5.
18. Commission on Genetics, Pregnancy, and the Child, International League Against Epilepsy. Guidelines of the care of women of childbearing age with epilepsy. Epilepsia 1993; 34: 588-9.
19. Tomson T, Gram L, Sillanpää M, Johannessen SI. Recommendations for the management and care of pregnant women with epilepsy. In: Tomson T, Gram L, Sillanpää M, Johannessen SI, eds. Epilepsy and pregnancy. Petersfield: Wrightson Biomedical Publishing Ltd 1997: 201-8.
20. MRC Vitamin Study Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-7.